{"id":58711,"date":"2021-04-05T13:42:00","date_gmt":"2021-04-05T11:42:00","guid":{"rendered":"https:\/\/www.verificat.cat\/covaxin-como-funciona\/"},"modified":"2021-04-05T11:44:00","modified_gmt":"2021-04-05T11:44:00","slug":"covaxin-como-funciona","status":"publish","type":"post","link":"https:\/\/www.verificat.cat\/es\/covaxin-como-funciona\/","title":{"rendered":"Covaxin"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>Covaxin es la primera vacuna 100% india, desarrollada por la compa&ntilde;&iacute;a de biotecnolog&iacute;a <a href=\"https:\/\/www.bharatbiotech.com\/index.html\" target=\"_blank\" rel=\"noopener\">Bharat Biotech<\/a> en colaboraci&oacute;n con el Consejo Indio de Investigaci&oacute;n M&eacute;dica y el Instituto Nacional de Virolog&iacute;a. Su f&oacute;rmula est&aacute; basada en un <a href=\"https:\/\/www.bharatbiotech.com\/covaxin.html\" target=\"_blank\" rel=\"noopener\">virus inactivado<\/a>. Usa una <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7189890\/\" target=\"_blank\" rel=\"noopener\">versi&oacute;n muerta del virus<\/a> que causa la enfermedad, incapaz de infectar pero que provoca una respuesta inmunitaria.<\/p>\n<p>En <a href=\"https:\/\/www.bharatbiotech.com\/covaxin.html\" target=\"_blank\" rel=\"noopener\">julio de 2020<\/a> comenzaron los ensayos cl&iacute;nicos y el 3 de marzo de 2021 fueron publicados los <a href=\"https:\/\/www.bharatbiotech.com\/images\/press\/covaxin-phase3-efficacy-results.pdf\" target=\"_blank\" rel=\"noopener\">resultados<\/a>. Un total de <a href=\"https:\/\/www.bharatbiotech.com\/images\/press\/covaxin-phase3-efficacy-results.pdf\" target=\"_blank\" rel=\"noopener\">25.800 personas<\/a> participaron en la fase III y la prueba ofreci&oacute; un <a href=\"https:\/\/www.bharatbiotech.com\/images\/press\/covaxin-phase3-efficacy-results.pdf\" target=\"_blank\" rel=\"noopener\">81% de eficacia<\/a>.<\/p>\n<p>Covaxin consiste en <a href=\"https:\/\/www.bharatbiotech.com\/covaxin.html\" target=\"_blank\" rel=\"noopener\">dos dosis<\/a> administradas con <a href=\"https:\/\/www.bharatbiotech.com\/covaxin.html\" target=\"_blank\" rel=\"noopener\">28 d&iacute;as de diferencia<\/a> y <a href=\"https:\/\/www.bharatbiotech.com\/covaxin.html\" target=\"_blank\" rel=\"noopener\">casi una decena de pa&iacute;ses<\/a> asi&aacute;ticos la est&aacute;n usando para inmunizar a sus poblaciones.<\/p>\n<p>Los <a href=\"https:\/\/www.bharatbiotech.com\/images\/covaxin\/covaxin-fact-sheet.pdf\" target=\"_blank\" rel=\"noopener\">efectos secundarios m&aacute;s reportados<\/a>, seg&uacute;n Bharat Biotech, son dolor, inflamaci&oacute;n o enrojecimiento en la zona del pinchazo, picor, sarpullidos, dolor de cabeza, fiebre, malestar corporal, n&aacute;useas y v&oacute;mitos. Las reacciones al&eacute;rgicas severas pueden producirse en muy raras ocasiones, seg&uacute;n la compa&ntilde;&iacute;a.<\/p>\n<p><a href=\"https:\/\/www.nationalheraldindia.com\/national\/this-is-how-india-has-planned-covishield-covaxin-storage\" target=\"_blank\" rel=\"noopener\">Covaxin<\/a> se conserva a una temperatura media de entre 2&ordm;C y 8&ordm;C.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Explicaci\u00f3n del funcionamiento y las caracter\u00edsticas de la vacuna<\/p>\n","protected":false},"author":3,"featured_media":19387,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[114],"tags":[115,116],"class_list":["post-58711","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud","tag-covid-19-verificaciones","tag-vacunes-verificaciones","vc-legacy-post"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/posts\/58711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/comments?post=58711"}],"version-history":[{"count":0,"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/posts\/58711\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/media\/19387"}],"wp:attachment":[{"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/media?parent=58711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/categories?post=58711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.verificat.cat\/es\/wp-json\/wp\/v2\/tags?post=58711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}